Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 20 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 11690839

    Treatment of idiopathic pulmonary fibrosis

    TAKEDA GMBH · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  2. US 11692229

    Fast diagnosis and personalized treatments for acne

    The Regents of the University of California · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  3. US 11690860

    Treatment of HCV infected patients with cirrhosis

    Atea Pharmaceuticals, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  4. US 11690829

    Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder

    OVID THERAPEUTICS INC. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  5. US 11690828

    Treatment of CNS diseases with sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  6. US 11679121

    Morpholino oligonucleotides useful in cancer treatment

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  7. US 11679093

    2-naphthimidamides, analogues thereof, and methods of treatment using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  8. US 11680062

    3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease

    Northwest A & F University · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  9. US 11679113

    Anticancer treatment for uveal melanoma

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  10. US 11680034

    Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

    PTC THERAPEUTICS, INC. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  11. US 11680067

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  12. US 11679112

    Cancer treatments using combinations of CDK and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  13. US 11673866

    Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases

    The Regents of the University of California · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted

  14. US 11667718

    Cancer treatment

    VANDA PHARMACEUTICALS INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted

  15. US 11666602

    Treatment of pulmonary arterial hypertension with mesenchymal stem cells

    United Therapeutics Corporation · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted

  16. US 11660277

    Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders

    OVID THERAPEUTICS INC. · Granted May 30, 2023 · Expires May 25, 2043

    granted

  17. US 11660296

    Treatment of chronic cough, breathlessness and dyspnea

    Trevi Therapeutics, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted

  18. US 11654193

    Cancer treatment combinations

    The Regents of the University of California · Granted May 23, 2023 · Expires May 18, 2043

    granted

  19. US 11648287

    Composition for the treatment of intracellular bacterial infection

    ACADEMISCH MEDISCH CENTRUM · Granted May 16, 2023 · Expires May 11, 2043

    granted

  20. US 11648247

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  21. US 11642384

    Compositions and methods for the treatment of Netherton Syndrome

    Krystal Biotech, Inc. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  22. US 11642390

    Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody

    REGENERON PHARMACEUTICALS, INC. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  23. US 11638704

    Bicyclic compounds and their use in the treatment of cancer

    TEMPEST THERAPEUTICS, INC. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted

  24. US 11638708

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.